Generating Conformation-Specific Polyclonal and Monoclonal Anti-Protein Kinase C Antibodies and Anti-Active State...

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Protein kinase C (PKC) family members act as either tumor suppressors or promoters in various cancers.
• Previous studies showed similar classical PKC (cPKC) expression in ER-positive and triple-negative breast cancer, but differing active cPKC levels.
• Kinase activation status is crucial for understanding tumor progression and therapeutic strategies.

Purpose of the Study:

• To describe a rational methodology for generating monoclonal and polyclonal antibodies against active classical PKC (cPKC) conformations.
• To enable the study of active kinase signaling dynamics in cancer and other diseases.
• To facilitate co-immunoprecipitation studies for identifying binding partners and substrates of active cPKCs.

Main Methods:

• Utilized antibodies that specifically recognize the active conformation of classical PKCs (cPKCs).
• Employed rational epitope selection by analyzing crystal structures of classical PKCs.
• Integrated molecular modeling studies to guide antibody development.

Main Results:

• Successfully developed monoclonal and polyclonal antibodies targeting the active state of cPKCs.
• Demonstrated the utility of these antibodies in distinguishing active cPKC levels in different breast cancer subtypes.
• Established a methodology applicable to other kinases and multi-domain enzymes undergoing conformational changes.

Conclusions:

• The developed anti-active state PKC antibodies are valuable tools for cancer research and clinical applications.
• This antibody generation strategy can be broadly applied to other conformationally dynamic enzymes.
• Understanding kinase activation status is key for advancing cancer diagnostics and therapeutics.